Cibc Private Wealth Group, LLC Dexcom Inc Transaction History

Cibc Private Wealth Group, LLC

$51.3 Billion
Q1 2025

A detailed history of Cibc Private Wealth Group, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 537,067 shares of DXCM stock, worth $32.9 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

537,067

Previous 395,940 35.64%

Holding current value

$32.9 Million

Previous $30.8 Million 19.11%

% of portfolio

0.07%

Previous 0.06%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	BUY	$67.74 - $90.75 $9.56 Million - $12.8 Million	141,127 Added 35.64%	537,067 $36.7 Million
Q4 2024 Feb 12, 2025	SELL	$65.68 - $81.01 $11.8 Million - $14.5 Million	-179,443 Reduced 31.19%	395,940 $30.8 Million
Q3 2024 Nov 13, 2024	BUY	$64.0 - $116.06 $366,272 - $664,211	5,723 Added 1.0%	575,383 $38.6 Million
Q2 2024 Aug 09, 2024	BUY	$110.31 - $140.45 $10.5 Million - $13.4 Million	95,293 Added 20.09%	569,660 $64.6 Million
Q1 2024 May 10, 2024	BUY	$114.22 - $140.1 $1.33 Million - $1.63 Million	11,665 Added 2.52%	474,367 $65.8 Million
Q4 2023 Feb 13, 2024	BUY	$75.49 - $124.16 $34.3 Million - $56.4 Million	453,917 Added 5166.96%	462,702 $57.4 Million
Q3 2023 Nov 13, 2023	SELL	$86.06 - $137.93 $32.3 Million - $51.8 Million	-375,224 Reduced 97.71%	8,785 $819,000
Q2 2023 Nov 21, 2023	BUY	$112.47 - $130.98 $42.2 Million - $49.1 Million	375,224 Added 4271.19%	384,009 $49.3 Million
Q2 2023 Aug 10, 2023	BUY	$112.47 - $130.98 $42.5 Million - $49.5 Million	377,945 Added 6232.6%	384,009 $49.3 Million
Q1 2023 Nov 21, 2023	SELL	$104.0 - $122.92 $282,984 - $334,465	-2,721 Reduced 30.97%	6,064 $704,000
Q1 2023 May 11, 2023	SELL	$104.0 - $122.92 $2.37 Million - $2.8 Million	-22,779 Reduced 78.98%	6,064 $704,000
Q4 2022 Jun 01, 2023	BUY	$84.98 - $122.67 $1.94 Million - $2.79 Million	22,779 Added 375.64%	28,843 $3.27 Million
Q4 2022 Feb 13, 2023	SELL	$84.98 - $122.67 $2.45 Million - $3.54 Million	-28,843 Reduced 50.0%	28,843 $3.27 Million
Q4 2022 Feb 13, 2023	BUY	$84.98 - $122.67 $2.04 Million - $2.94 Million	23,987 Added 71.18%	57,686 $6.53 Million
Q3 2022 Nov 14, 2022	BUY	$76.35 - $94.18 $2.09 Million - $2.58 Million	27,435 Added 437.98%	33,699 $2.71 Million
Q2 2022 Aug 03, 2022	BUY	$67.99 - $132.89 $322,272 - $629,898	4,740 Added 311.02%	6,264 $467,000
Q1 2022 May 16, 2022	SELL	$94.08 - $130.2 $26,812 - $37,107	-285 Reduced 15.75%	1,524 $780,000
Q4 2021 Feb 08, 2022	BUY	$129.87 - $162.82 $95,844 - $120,161	738 Added 68.91%	1,809 $971,000
Q3 2021 Nov 12, 2021	SELL	$106.71 - $143.18 $78,645 - $105,523	-737 Reduced 40.76%	1,071 $586,000
Q2 2021 Aug 16, 2021	BUY	$80.99 - $107.93 $566 - $755	7 Added 0.39%	1,808 $772,000
Q1 2021 May 12, 2021	BUY	$84.79 - $104.74 $3,815 - $4,713	45 Added 2.56%	1,801 $647,000
Q4 2020 Feb 12, 2021	SELL	$78.0 - $104.5 $1,716 - $2,299	-22 Reduced 1.24%	1,756 $649,000
Q3 2020 Nov 03, 2020	BUY	$95.51 - $112.95 $99,139 - $117,242	1,038 Added 140.27%	1,778 $728,000
Q3 2020 Oct 29, 2020	BUY	$95.51 - $112.95 $70,677 - $83,583	740 New	740 $305,000
Q2 2020 Aug 13, 2020	SELL	$62.68 - $105.34 $456,937 - $767,928	-7,290 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$47.79 - $75.63 $267,146 - $422,771	5,590 Added 328.82%	7,290 $1.96 Million
Q4 2019 Jan 30, 2020	SELL	$36.62 - $57.29 $476 - $744	-13 Reduced 0.76%	1,700 $372,000
Q3 2019 Oct 16, 2019	BUY	$35.53 - $43.8 $60,862 - $75,029	1,713 New	1,713 $256,000
Q3 2018 Nov 14, 2018	SELL	$23.35 - $36.72 $23,350 - $36,720	-1,000 Closed	0 $0
Q4 2017 Feb 12, 2018	BUY	$11.12 - $15.38 $11,120 - $15,380	1,000	1,000 $57,000

Others Institutions Holding DXCM

# of Institutions

1,107

Shares Held

366M

Call Options Held

5.36M

Put Options Held

5.18M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $23.6B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Private Wealth Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cibc Private Wealth Group, LLC with notifications on news.

Account

Cibc Private Wealth Group, LLC Dexcom Inc Transaction History